These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 24738736

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Renal effects of soluble guanylate cyclase stimulators and activators: a review of the preclinical evidence.
    Stasch JP, Schlossmann J, Hocher B.
    Curr Opin Pharmacol; 2015 Apr; 21():95-104. PubMed ID: 25645316
    [Abstract] [Full Text] [Related]

  • 23. Regulation of soluble guanylyl cyclase-alpha1 expression in chronic hypoxia-induced pulmonary hypertension: role of NFATc3 and HuR.
    de Frutos S, Nitta CH, Caldwell E, Friedman J, González Bosc LV.
    Am J Physiol Lung Cell Mol Physiol; 2009 Sep; 297(3):L475-86. PubMed ID: 19592461
    [Abstract] [Full Text] [Related]

  • 24. Guanylyl cyclase activation reverses resistive breathing-induced lung injury and inflammation.
    Glynos C, Toumpanakis D, Loverdos K, Karavana V, Zhou Z, Magkou C, Dettoraki M, Perlikos F, Pavlidou A, Kotsikoris V, Topouzis S, Theocharis SE, Brouckaert P, Giannis A, Papapetropoulos A, Vassilakopoulos T.
    Am J Respir Cell Mol Biol; 2015 Jun; 52(6):762-71. PubMed ID: 25353067
    [Abstract] [Full Text] [Related]

  • 25. Tirofiban increases soluble guanylate cyclase in rat vascular walls: pharmacological and pathophysiological consequences.
    Ruiz-Torres MP, Griera M, Chamorro A, Díez-Marqués ML, Rodríguez-Puyol D, Rodríguez-Puyol M.
    Cardiovasc Res; 2009 Apr 01; 82(1):125-32. PubMed ID: 19126601
    [Abstract] [Full Text] [Related]

  • 26. Inhaled agonists of soluble guanylate cyclase induce selective pulmonary vasodilation.
    Evgenov OV, Kohane DS, Bloch KD, Stasch JP, Volpato GP, Bellas E, Evgenov NV, Buys ES, Gnoth MJ, Graveline AR, Liu R, Hess DR, Langer R, Zapol WM.
    Am J Respir Crit Care Med; 2007 Dec 01; 176(11):1138-45. PubMed ID: 17872487
    [Abstract] [Full Text] [Related]

  • 27. Role of CXCL13 in cigarette smoke-induced lymphoid follicle formation and chronic obstructive pulmonary disease.
    Bracke KR, Verhamme FM, Seys LJ, Bantsimba-Malanda C, Cunoosamy DM, Herbst R, Hammad H, Lambrecht BN, Joos GF, Brusselle GG.
    Am J Respir Crit Care Med; 2013 Aug 01; 188(3):343-55. PubMed ID: 23742729
    [Abstract] [Full Text] [Related]

  • 28. Dehydroepiandrosterone upregulates soluble guanylate cyclase and inhibits hypoxic pulmonary hypertension.
    Oka M, Karoor V, Homma N, Nagaoka T, Sakao E, Golembeski SM, Limbird J, Imamura M, Gebb SA, Fagan KA, McMurtry IF.
    Cardiovasc Res; 2007 Jun 01; 74(3):377-87. PubMed ID: 17346686
    [Abstract] [Full Text] [Related]

  • 29. Soluble guanylate cyclase modulates alveolarization in the newborn lung.
    Bachiller PR, Cornog KH, Kato R, Buys ES, Roberts JD.
    Am J Physiol Lung Cell Mol Physiol; 2013 Oct 15; 305(8):L569-81. PubMed ID: 23934926
    [Abstract] [Full Text] [Related]

  • 30. Regulation of the expression of soluble guanylyl cyclase by reactive oxygen species.
    Gerassimou C, Kotanidou A, Zhou Z, Simoes DC, Roussos C, Papapetropoulos A.
    Br J Pharmacol; 2007 Apr 15; 150(8):1084-91. PubMed ID: 17339839
    [Abstract] [Full Text] [Related]

  • 31. Statin reverses smoke-induced pulmonary hypertension and prevents emphysema but not airway remodeling.
    Wright JL, Zhou S, Preobrazhenska O, Marshall C, Sin DD, Laher I, Golbidi S, Churg AM.
    Am J Respir Crit Care Med; 2011 Jan 01; 183(1):50-8. PubMed ID: 20709821
    [Abstract] [Full Text] [Related]

  • 32. Stimulation of soluble guanylate cyclase slows progression in anti-thy1-induced chronic glomerulosclerosis.
    Wang Y, Krämer S, Loof T, Martini S, Kron S, Kawachi H, Shimizu F, Neumayer HH, Peters H.
    Kidney Int; 2005 Jul 01; 68(1):47-61. PubMed ID: 15954895
    [Abstract] [Full Text] [Related]

  • 33. Therapeutic potential of soluble guanylate cyclase modulators in neonatal chronic lung disease.
    Wagenaar GT, Hiemstra PS, Gosens R.
    Am J Physiol Lung Cell Mol Physiol; 2015 Nov 15; 309(10):L1037-40. PubMed ID: 26432873
    [Abstract] [Full Text] [Related]

  • 34. Discovery of riociguat (BAY 63-2521): a potent, oral stimulator of soluble guanylate cyclase for the treatment of pulmonary hypertension.
    Mittendorf J, Weigand S, Alonso-Alija C, Bischoff E, Feurer A, Gerisch M, Kern A, Knorr A, Lang D, Muenter K, Radtke M, Schirok H, Schlemmer KH, Stahl E, Straub A, Wunder F, Stasch JP.
    ChemMedChem; 2009 May 15; 4(5):853-65. PubMed ID: 19263460
    [Abstract] [Full Text] [Related]

  • 35. Endothelial nitric oxide synthase-enhancing G-protein coupled receptor antagonist inhibits pulmonary artery hypertension by endothelin-1-dependent and endothelin-1-independent pathways in a monocrotaline model.
    Liu CP, Dai ZK, Huang CH, Yeh JL, Wu BN, Wu JR, Chen IJ.
    Kaohsiung J Med Sci; 2014 Jun 15; 30(6):267-78. PubMed ID: 24835346
    [Abstract] [Full Text] [Related]

  • 36. Pulmonary inflammatory reaction and structural changes induced by cigarette smoke exposure in the Guinea pig.
    Domínguez-Fandos D, Peinado VI, Puig-Pey R, Ferrer E, Musri MM, Ramírez J, Barberà JA.
    COPD; 2012 Aug 15; 9(5):473-84. PubMed ID: 22708688
    [Abstract] [Full Text] [Related]

  • 37. The chemistry and biology of soluble guanylate cyclase stimulators and activators.
    Follmann M, Griebenow N, Hahn MG, Hartung I, Mais FJ, Mittendorf J, Schäfer M, Schirok H, Stasch JP, Stoll F, Straub A.
    Angew Chem Int Ed Engl; 2013 Sep 02; 52(36):9442-62. PubMed ID: 23963798
    [Abstract] [Full Text] [Related]

  • 38. P2X7 receptor signaling in the pathogenesis of smoke-induced lung inflammation and emphysema.
    Lucattelli M, Cicko S, Müller T, Lommatzsch M, De Cunto G, Cardini S, Sundas W, Grimm M, Zeiser R, Dürk T, Zissel G, Sorichter S, Ferrari D, Di Virgilio F, Virchow JC, Lungarella G, Idzko M.
    Am J Respir Cell Mol Biol; 2011 Mar 02; 44(3):423-9. PubMed ID: 20508069
    [Abstract] [Full Text] [Related]

  • 39. Sildenafil in a cigarette smoke-induced model of COPD in the guinea-pig.
    Domínguez-Fandos D, Valdés C, Ferrer E, Puig-Pey R, Blanco I, Tura-Ceide O, Paul T, Peinado VI, Barberà JA.
    Eur Respir J; 2015 Aug 02; 46(2):346-54. PubMed ID: 25929951
    [Abstract] [Full Text] [Related]

  • 40. Role of Cigarette Smoke-Induced Aggresome Formation in Chronic Obstructive Pulmonary Disease-Emphysema Pathogenesis.
    Tran I, Ji C, Ni I, Min T, Tang D, Vij N.
    Am J Respir Cell Mol Biol; 2015 Aug 02; 53(2):159-73. PubMed ID: 25490051
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.